期刊
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
卷 23, 期 1-3, 页码 109-114出版社
KARGER
DOI: 10.1159/000204099
关键词
Alzheimer's disease; beta-amyloid peptide; Depolarization; Gait disorders; Muscle
资金
- RFBR [07-04-01331]
- RF President [NSh-3368.2008.4]
- Asklepios-Med Bt
Numerous findings obtained over the last decades suggest that accumulation of beta-amyloid peptide (beta AP) plays the central role in the pathogenesis of Alzheimer's disease. It is well established that beta AP has wide range of toxic effects on neurons in vitro and in vivo, however the influence of beta AP in the periphery and on various other types of excitable tissues, eg. skeletal muscle cells, is almost unknown despite the many non-cognitive and other extraneuronal symptoms associated with Alzheimer's dementia. Here we utilized conventional electrophysiological technique to investigate the effects and mechanisms of beta AP action on the resting membrane potential of frog skeletal muscle fibers. beta AP in the range of concentrations from 10(-6) to 10(-8)M produced slow, significant, reversible depolarization of muscle fiber membranes. The impact developed and was washed out faster at higher concentrations of beta AP (10(-6) - 10(-7)M). The effect of beta AP was completely absent when applied in Na+-free Tris(+)solutions. beta AP-mediated depolarization was also prevented by tetrodotoxin ( 10(-5)M) pre-treatment and rescued by tetrodotoxin after-treatment. These findings suggest that beta AP-induced depolarization of skeletal muscle plasma membranes can significantly disturb the functioning of skeletal muscles and therefore contribute to motor dysfunction observed in Alzheimer's disease and other disorders associated with beta AP accumulation. Copyright (C) 2009 S. Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据